Cannabis Strategic Ventures Inc. (NUGS) Seeks OTCQB Venture

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
453
Cannabis Strategic Ventures Inc. (NUGS) Seeks OTCQB Venture Market Uplisting as Part of Growth Strategy

- The company is on target to meet the more stringent reporting standards and compliance requirements for a successful uplisting
- Niche acquisitions and a vertically-integrated strategy will further enable the company’s sustainable market growth in the years to come
- Cannabis Strategic Ventures aims to create and control specific cannabis industry niches through focused brand development and acquisitions of hard assets for growth, distribution and manufacturing

Los Angeles-based cannabis industry incubator Cannabis Strategic Ventures Inc. (OTC: NUGS) recently submitted its application to uplist to the OTCQB Venture Market, a move that supports the company’s broader, acquisition-based growth strategy. According to a press release, OTCQB uplisting requires compliance with more rigorous criteria, transparent financial reporting and completion of an extensive certification and verification process (http://nnw.fm/9OLgB).

Following the proposed uplisting, the company will need to maintain a minimum share price and provide investors with increased transparency, which could result in greater liquidity and awareness. Cannabis Strategic Ventures’ management is confident that all of these requirements are fully met.

“We have many new initiatives planned in 2019 and we are managing our business operations for growth. This uplisting is designed to demonstrate to our investors and to the marketplace that Cannabis Strategic Ventures is well-prepared for the future,” Cannabis Strategic Ventures CEO Simon Yu stated in a news release.

The uplisting supports the company’s broader growth strategy, which is primarily based on acquisitions of both cannabidiol brands and hard assets, such as growth facilities. A diversified portfolio will allow Cannabis Strategic Ventures to tap into multiple market niches and capitalize on the constantly growing cannabis sector.

According to forecasts, legal cannabis spending worldwide will increase from $20.1 billion in 2018 to $43.3 billion in 2022 and $63.5 billion in 2024 (http://nnw.fm/1Uhp5). In North America alone, the industry is expected to grow from $9.2 billion in 2017 to $47.3 billion just a decade later (http://nnw.fm/4VXpe). Industry analysis suggests that recreational use will dominate sales in North America, while medical use will yield more sales in Europe.

Cannabis Strategic Ventures aims to create and control specific cannabis industry niches by developing cannabis consumer brands. The company’s approach is based on experience in an array of key fields, including cannabis cultivation; personnel services for the cannabis industry; product development; and technological solutions that meet the needs of manufacturers, cultivators, dispensaries and other legal cannabis industry representatives.

The Cannabis Strategic Ventures portfolio already features a collection of niche brands like Halo Filters, The Asher House Wellness, Fitamins, LYXR and Pure Applied Sciences.

The company continues to invest in and develop companies within the cannabis and ancillary sectors. Both startups and growth stage businesses are of interest to the Cannabis Strategic Ventures leadership team. The company provides the capital, know-how and networking opportunities required to ensure the fast and sustainable growth of represented brands.

Additionally, Cannabis Strategic Ventures is working toward expanding its product lines to feature beauty products, while cultivation and manufacturing strategies featured in the corporate portfolio enable better vertical integration.

For more information, visit the company’s website at www.CannabisStrategic.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

CompoSecure's Adam Lowe Executes $490K Stock Sale and Insights

Updated Category News Views 302

Adam Lowe's Notable Stock Transactions Revealed Adam Lowe, the Chief Product & Innovation Officer at CompoSecure, Inc. (NASDAQ: CMPO), has recently stirred up some buzz following his stock sales, which amounted to over $490,000. According to recent regulatory filings, on a pivotal day, Lowe sold 40,658 shares of CompoSecure's Class A Common Stock, netting him $490,335...

Continue Reading
Extendicare Reports Strong Q4 and Year-End Results with Dividend Boost

Updated Category News Views 299

Extendicare's Positive Financial Performance in Q4 2024 Extendicare Inc. (TSX: EXE) has released its results for the last quarter of 2024, showcasing significant growth and a successful year overall. The company, known for its commitment to quality care for seniors across Canada, reported a remarkable increase in adjusted EBITDA, a key indicator of financial performance,...

Continue Reading
The Kayon's New Villas: Ubud's Intimate Luxury Retreat

Updated Category News Views 10

Embracing Exclusive Escapes in Ubud A couple of days ago, The Kayon Resort decided to stir the pot in Ubud's luxury accommodation landscape by rolling out two swanky villa categories: the Premier Pool Villa and the Royal Jacuzzi Pool Villa. No pandering here, just straight-up elegance mingling with nature. Why Ubud's Going Gaga Over Privacy People are craving privacy and...

Continue Reading
Exploring the Vibrant Growth of the Outdoor Backpacks Market

Updated Category News Views 147

The Outdoor Backpacks Market Growth Story The Outdoor Backpacks Market is experiencing remarkable growth, expected to increase by USD 997.1 million between 2025 and 2029. This growth reflects a projected CAGR of approximately 5.4%, driven primarily by rising interest in hiking among millennials. Today's outdoor enthusiasts are not just looking for gear; they desire...

Continue Reading
Nuveen Closed-End Funds Share Updated Distribution Notices

Updated Category News Views 79

Nuveen stirred the pot back in 2024 with a fresh drop on their closed-end funds (CEFs), rolling out distribution notices that laid bare the guts of their quarterly payouts. Yeah, those notices were packed with juicy details about where investors' cash was coming from—like net investment income and capital gains—but they also signaled some unsettling shifts lurking...

Continue Reading